Bnp Paribas Arbitrage, Snc »

Summit Therapeutics shares owned by Bnp Paribas Arbitrage, Snc

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Bnp Paribas Arbitrage, Snc from 13F filings

Historical chart of Bnp Paribas Arbitrage, Snc investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Bnp Paribas Arbitrage, Snc consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Bnp Paribas Arbitrage, Snc

Quarter filed Position value Share count Share price at filing
2025-09-30 $603k 29k 20.66
2025-06-30 $635k 30k 21.28
2025-03-31 $21M 1.1M 19.29
2024-12-31 $8.8M 493k 17.85
2022-09-30 $1.4k 1.2k 1.19